A Thai-French firm says its development of a vaccine for Covid-19 is at an advanced stage, with human trials set to begin in the next few weeks.
Biotechnology company BioNet-Asia is currently testing whether the candidate vaccine is effective in mice. If so, the firm will begin conducting two vaccine trials on humans, said company founder Vitoon Wonghanku.
The Public Health Ministry is supervising the development of the Covid-19 vaccine, while the results of the project are being passed on to the World Health Organisation (WHO), he added.
The candidate vaccine was injected into mice on April 9. It will take scientists about five weeks to measure whether it is effective, with animal trial results expected in May.
So far, between Bt100 million and Bt200 million has been invested in the project. Another 500 million to 1 billion dollars will be spent on the next phases, including human trials and product registration.